Skip to main content
OpenTrials

Clinical trial condition

Acquired Immunodeficiency Syndrome

Explore clinical trials studying Acquired Immunodeficiency Syndrome. Study availability and eligibility vary by location and protocol.

2,558 public trials 178 recruiting studies
Refine in advanced search Browse all conditions

Acquired Immunodeficiency Syndrome trial results

Completed

A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin

NCT00000778

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Actinomycetales Infections, +25 more
Locations
  • Univ of Alabama at Birmingham Birmingham, Alabama, United States
  • UCLA Med Ctr Los Angeles, California, United States
  • Harbor - UCLA Med Ctr Torrance, California, United States
  • Broward Gen Med Ctr Fort Lauderdale, Florida, United States
View Trial Details
Completed

A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex

NCT00000976

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Univ of California / San Diego Treatment Ctr San Diego, California, United States
  • Univ of Miami School of Medicine Miami, Florida, United States
  • Univ of Massachusetts Worcester, Massachusetts, United States
View Trial Details
Completed

The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the Treatment of Mycobacterium Avium Complex (MAC) Infections in Children With AIDS

NCT00000971

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Actinomycetales Infections, +23 more
Locations
  • Children's Hosp of Los Angeles Los Angeles, California, United States
  • Natl Cancer Institute / HIV / AIDS Malignancy Branch Bethesda, Maryland, United States
View Trial Details
Completed

A Randomized Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patients With HIV Infection

NCT00000760

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • UCSD San Diego, California, United States
  • Johns Hopkins Hosp Baltimore, Maryland, United States
  • Harvard (Massachusetts Gen Hosp) Boston, Massachusetts, United States
  • Case Western Reserve Univ Cleveland, Ohio, United States
View Trial Details
Completed

The Safety and Effectiveness of BI-RG-587 in HIV-Infected Patients

NCT00000962

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • Univ of California / San Diego Treatment Ctr San Diego, California, United States
  • Univ of Massachusetts Med Ctr Worcester, Massachusetts, United States
  • Univ of Minnesota Minneapolis, Minnesota, United States
View Trial Details
Completed

An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 400/mm3)

NCT00000649

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • Cooper Green Hosp Birmingham, Alabama, United States
  • Univ of California / San Diego Treatment Ctr San Diego, California, United States
  • Univ of Massachusetts Worcester, Massachusetts, United States
View Trial Details
Completed

A Pharmacokinetic Study of L-697,661 Alone and in Combination With Zidovudine

NCT00000628

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • San Francisco Gen Hosp San Francisco, California, United States
  • Univ of Colorado Health Ctr / Denver Gen Hosp Denver, Colorado, United States
  • Northwestern Univ Med School Chicago, Illinois, United States
  • Rush Presbyterian - Saint Luke's Med Ctr Chicago, Illinois, United States
View Trial Details

Related conditions